Statistical rigor and technological excellence drive us. We are impacting patient lives, and we hold ourselves to the highest standards.
Run the Experiment
Unlearn was founded by scientists and we take a scientific approach to all aspects of our business.
Invent for the Customer
We are relentless about inventing solutions that shorten clinical trial timelines.
Culture and team
Unlearn was started to solve hard problems. We foster an environment and culture that empowers everyone to do their best work, so we can find solutions together.
Moneyball Medicine Podcast #49: Charles Fisher on Using Digital Twins to Speed Clinical Trials
October 29, 2020
By comparing a patient’s actual record to their Digital Twin, Unlearn can estimate the treatment effect at the patient level and conduct trials with fewer patients.
Unlearn.AI Announces Series A Extension with New Investment from Epic Ventures, Alumni Ventures Group, and Global Pharma Company Eisai
November 5, 2020
Eisai has joined the company’s world-class syndicate of investors as part of its Series A extension along with Epic Ventures and Alumni Ventures Group.
